Prognostic value of serum chemerin in critically ill patients with sepsis: a prospective study
I. Karampela (Athens, Greece), G. Christodoulatos (Athens, Greece), N. Vallianou (Athens, Greece), D. Tsilingiris (Athens, Greece), E. Chrysanthopoulou (Athens, Greece), G. Skyllas (Athens, Greece), G. Antonakos (Athens, Greece), I. Marinou (Athens, Greece), E. Vogiatzakis (Athens, Greece), A. Armaganidis (Athens, Greece), M. Dalamaga (Athens, Greece)
Source: International Congress 2022 – COVID-19 acute respiratory distress syndrome and beyond
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Karampela (Athens, Greece), G. Christodoulatos (Athens, Greece), N. Vallianou (Athens, Greece), D. Tsilingiris (Athens, Greece), E. Chrysanthopoulou (Athens, Greece), G. Skyllas (Athens, Greece), G. Antonakos (Athens, Greece), I. Marinou (Athens, Greece), E. Vogiatzakis (Athens, Greece), A. Armaganidis (Athens, Greece), M. Dalamaga (Athens, Greece). Prognostic value of serum chemerin in critically ill patients with sepsis: a prospective study. 2317
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|